- Why Indian pharma isn’t panicking on Trump’s threat of 200% tariff on generics Moneycontrol.com
- Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines The Times of India
- Trump rolls out new tariff policy for generic medicines, 200% levy to kick in after August 2028 transition Deccan Herald
- Indias Generic Drug Exports Now Face New US Tariff Threat TheWire.in
- Trump’s tariff threat on generic drugs: Why this matters for Indian pharma companies The Indian Express
Why Indian pharma isn’t panicking on Trump’s threat of 200% tariff on generics Moneycontrol.comTrump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines The Times of IndiaTrump rolls out new tariff policy for generic medicines, 200% levy to kick in after August 2028 transition Deccan HeraldIndias Generic Drug Exports Now Face New US Tariff Threat TheWire.inTrump’s tariff threat on generic drugs: Why this matters for Indian pharma companies The Indian Express by Soban News (international And National News)